SCHEMBL17640487

SCHEMBL17640487

c1ccc2c(c1)c1ccccc1n2-c1ccc(-c2nsc(-c3ccc(-n4c5ccccc5c5ccccc54)cc3)n2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP19A1 P11511 4/20 0.50
▸ MAPT P10636 2/20 0.47
▸ KDM4E B2RXH2 1/20 0.46
▸ ATM Q13315 1/20 0.46
▸ L3MBTL1 Q9Y468 1/20 0.46
▸ HSD17B1 P14061 2/20 0.42
▸ HSD17B2 P37059 2/20 0.42
▸ ADORA3 P0DMS8 3/20 0.40
▸ ADORA2A P29274 3/20 0.40
▸ ADORA2B P29275 3/20 0.40
▸ ADORA1 P30542 3/20 0.40
▸ SNCA P37840 1/20 0.40
▸ HDAC4 P56524 1/20 0.36
▸ PTPN1 P18031 2/20 0.34
▸ MEN1 O00255 1/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ CASP3 P42574 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ SENP8 Q96LD8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17640568 0.92 CYP19A1 (0.45) CYP19A1MAPTKDM4EATML3MBTL1
SCHEMBL21915396 0.90 CYP19A1 (0.41) CYP19A1MAPTKDM4EATML3MBTL1
SCHEMBL21915289 0.89 HSD17B1 (0.46) CYP19A1MAPTKDM4EATML3MBTL1
SCHEMBL21915424 0.89 MAPT (0.40) CYP19A1MAPTKDM4EATML3MBTL1
SCHEMBL17640549 0.89 CYP19A1 (0.43) CYP19A1MAPTKDM4EATML3MBTL1
SCHEMBL17640581 0.89 CYP19A1 (0.43) CYP19A1MAPTKDM4EATML3MBTL1
SCHEMBL21915414 0.88 MAPT (0.40) CYP19A1MAPTKDM4EATML3MBTL1
SCHEMBL20413138 0.88 CYP19A1 (0.42) CYP19A1MAPTKDM4EATML3MBTL1
SCHEMBL21915393 0.87 CYP19A1 (0.39) CYP19A1MAPTKDM4EATML3MBTL1
SCHEMBL21915858 0.86 HSD17B1 (0.38) CYP19A1MAPTKDM4EATML3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10333078-B2 Fluorescent organic light emitting elements having high efficiency UDC IRELAND LIMITED (IE) 2019-06-25 — — US disclosed
US-20170309828-A1 Fluorescent Organic Light Emitting Elements Having High Efficiency BASF SE (DE) 2017-10-26 — — US disclosed
US-20170309828-A1 Fluorescent Organic Light Emitting Elements Having High Efficiency BASF SE (DE) 2017-10-26 — — US disclosed
WO-2016046350-A1 FLUORESCENT ORGANIC LIGHT EMITTING ELEMENTS HAVING HIGH EFFICIENCY BASF SE (DE) 2016-03-31 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10333078-B2 Fluorescent organic light emitting elements having high efficiency NR2E3, CRY1, ALDH1A2 CYP19A1 2245/4885MAPT 2708/4885KDM4E 2431/4885
US-20170309828-A1 Fluorescent Organic Light Emitting Elements Having High Efficiency NR2E3, CRY1, ALDH1A2 CYP19A1 2245/4885MAPT 2708/4885KDM4E 2431/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback